Skip to main content

Table 2 Gastrointestinal symptoms and scores of the UCLA GIT 2.0 and its subscales in all visits, N = 940

From: Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis

  n %  
Heartburn 323 (35.2)  
Regurgitation 123 (13.4)  
Dysphagia 184 (20.1)  
Early satiety 106 (11.6)  
Vomiting 34 (3.7)  
Upper abdomen pain 26 (2.8)  
Bloating 157 (17.1)  
Diarrhea 84 (9.2)  
Constipation 109 (11.9)  
Fecal incontinence 58 (6.3)  
UCLA GIT 2.0 subscales Median Q1, Q3 Range
Reflux 0.25 0.00, 0.63 (0–3)
Distention/bloating 0.50 0.00, 1.00 (0–3)
Fecal soilage 0.00 0.00, 0.00 (0–3)
Diarrhea 0.00 0.00, 0.50 (0–2)
Social functioning 0.00 0.00, 0.33 (0–2.5)
Emotional wellbeing 0.00 0.00, 0.22 (0–3)
Constipation 0.00 0.00, 0.50 (0–2.5)
Total score of UCLA GIT 2.0 0.22 0.07, 0.49 (0–2.4)